1-1 of 1
Rob Ruijtenbeek, PhD
Close
Sort by
Journal Articles

Application of Kinase Activity Profiles to Predict Upcoming TKI Resistance In CML-Patients.

Piet Boender, PhD, Jeroen Janssen, MD., PhD, Linda Smit, PhD, Rob Ruijtenbeek, PhD, Adrienne van den Berg, BSc, Rik de Wijn, PhD, Gert J. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3425.
https://doi.org/10.1182/blood.V116.21.3425.3425
Published: 2010